Synthesis of novel pyrimido[4,5‐b]quinoline derivatives as dual EGFR/HER2 inhibitors as anticancer agents
- 26 December 2023
- journal article
- research article
- Published by Wiley in Archiv der Pharmazie
- Vol. 357 (3) , e2300513
Abstract
A series of novel N‐aryl‐5‐aryl‐6,7,8,9‐tetrahydropyrimido[4,5‐b]quinolin‐4‐amines 4a–4l was synthesized as potential anticancer agents through Dimroth rearrangement reaction of intermediates 3a–3c. Pyrimido[4,5‐b]quinolines 4a–4l showed promising activity against the Michigan Cancer Foundation‐7 (MCF‐7) cell line, compared with lapatinib as the reference drug. Compounds 4d, 4h, 4i, and 4l demonstrated higher cytotoxic activity than lapatinib, with IC50 values of 2.67, 6.82, 4.31, and 1.62 µM, respectively. Compounds 4d, 4i, and 4l showed promising epidermal growth factor receptor (EGFR) inhibition with IC50 values of 0.065, 0.116, and 0.052 µM, respectively. These compounds were subjected to human epidermal growth factor receptor 2 (HER2) inhibition and showed IC50 values of 0.09, 0.164, and 0.055 µM, respectively. Compounds 4d, 4i, and 4l are good candidates as dual EGFR/HER2 inhibitors. The most active compound, 4l, was subjected to cell‐cycle analysis and induced cell‐cycle arrest at the S phase. Compound 4l induced apoptosis 60‐fold compared with control untreated MCF‐7 cells. 4l can inhibit cancer metastasis. It reduced MCF‐7 cell infiltration and metastasis by 45% compared with control untreated cells.Keywords
Funding Information
- Faculty of Pharmacy, Cairo University
This publication has 59 references indexed in Scilit:
- Knoevenagel condensation catalyzed by a tertiary-amine functionalized polyacrylonitrile fiberGreen Chemistry, 2011
- Synthesis, in vitro antimicrobial and in vivo antitumor evaluation of novel pyrimidoquinolines and its nucleoside derivativesEuropean Journal of Medicinal Chemistry, 2011
- The role of HER2 in cancer therapy and targeted drug deliveryJournal of Controlled Release, 2010
- Novel quinolines and pyrimido[4,5-b]quinolines bearing biologically active sulfonamide moiety as a new class of antitumor agentsEuropean Journal of Medicinal Chemistry, 2010
- Design, synthesis and anticancer evaluation of novel tetrahydroquinoline derivatives containing sulfonamide moietyEuropean Journal of Medicinal Chemistry, 2009
- New acyclic nucleosides analogues as potential analgesic, anti-inflammatory, anti-oxidant and anti-microbial derived from pyrimido[4,5-b]quinolinesEuropean Journal of Medicinal Chemistry, 2009
- Synthesis and anti-breast cancer activities of substituted quinolinesBioorganic & Medicinal Chemistry Letters, 2008
- The epidermal growth factor receptor in malignant gliomas: pathogenesis and therapeutic implicationsExpert Opinion on Therapeutic Targets, 2007
- Facile Synthesis of 5, 6, 7, 8-Tetrahydropyrimido [4, 5-b]-quinoline DerivativesMolecules, 2006
- Gefitinib, a selective EGFR tyrosine kinase inhibitor, induces apoptosis through activation of Bax in human gallbladder adenocarcinoma cellsJournal of Cellular Biochemistry, 2005